Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+231.6%
5Y CAGR+137.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+231.6%/yr
Annual compound
5Y CAGR
+137.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
75.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$22.60M+183.4%
2024$7.97M+4674.3%
2023$167000.00-73.1%
2022$620000.00+19.0%
2021$521000.00+73.7%
2020$300000.00+3650.0%
2019$8000.00-
2018$0.00-